These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 19530)
1. The antibody response to the T1699 murine adenocarcinoma: antibody class and subclass heterogeneity detected in serum and in situ. Haskill JS; Radov LA; Fett JW; Parthenais E J Immunol; 1977 Sep; 119(3):1000-5. PubMed ID: 19530 [TBL] [Abstract][Full Text] [Related]
2. Immunity to the T1699 murine mammary tumor. I. Thymic influence and long-term effect of irradiation on the humoral response. Parthenais E; Haskill S J Immunol; 1979 Sep; 123(3):1329-33. PubMed ID: 381522 [TBL] [Abstract][Full Text] [Related]
3. Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice. DeLustro F; Haskill JS J Natl Cancer Inst; 1980 Jan; 64(1):125-30. PubMed ID: 6928037 [TBL] [Abstract][Full Text] [Related]
4. Antibody response to embryonal carcinoma cells in syngeneic mice. Damonneville M; Morello D; Gachelin G; Stanislawski M Eur J Immunol; 1979 Dec; 9(12):932-7. PubMed ID: 549777 [TBL] [Abstract][Full Text] [Related]
5. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo. Haskill JS; Fett JW J Immunol; 1976 Nov; 117(5 Pt.2):1992-8. PubMed ID: 993593 [TBL] [Abstract][Full Text] [Related]
6. Modulation of thymus-leukemia antigens on mouse leukemia cells induced by IgG, but not IgM, antibody. Stackpole CW J Natl Cancer Inst; 1980 Apr; 64(4):917-23. PubMed ID: 6929003 [TBL] [Abstract][Full Text] [Related]
7. Macrophage-mediated, antibody-dependent destruction of tumor cells in DBA/2 mice: in vitro identification of an in situ mechanism. Key M; Haskill S J Natl Cancer Inst; 1981 Jan; 66(1):103-10. PubMed ID: 7005500 [TBL] [Abstract][Full Text] [Related]
8. Complement receptor lymphocytes. Analysis of immunoglobin on their surface and further evidence of heterogeneity. Arnaiz-Villena A; Hay FC Immunology; 1975 Apr; 28(4):719-29. PubMed ID: 1097333 [TBL] [Abstract][Full Text] [Related]
9. Murine cytomegalovirus infection model in Balb/c mice. 3. Immunoglobulin production during infection. Leung WC; Hashimoto K; Umehara K; Hata J Tokai J Exp Clin Med; 1991 Mar; 16(1):11-20. PubMed ID: 1664146 [TBL] [Abstract][Full Text] [Related]
10. Immunologic factors influencing the intra-tumor localization of ADCC effector cells. Haskill S; Parthenais E J Immunol; 1978 Jun; 120(6):1813-7. PubMed ID: 659877 [TBL] [Abstract][Full Text] [Related]
11. Human heterophilic antibodies display specificity for murine IgG subclasses. Bjerner J; Olsen KH; Børmer OP; Nustad K Clin Biochem; 2005 May; 38(5):465-72. PubMed ID: 15820778 [TBL] [Abstract][Full Text] [Related]
12. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. Snapper CM; Waegell W; Beernink H; Dasch JR J Immunol; 1993 Nov; 151(9):4625-36. PubMed ID: 8409423 [TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. Dhein J; Daniel PT; Trauth BC; Oehm A; Möller P; Krammer PH J Immunol; 1992 Nov; 149(10):3166-73. PubMed ID: 1431095 [TBL] [Abstract][Full Text] [Related]
15. The H-2 haplotype of a thymus graft influences the Ir gene regulated IgG3, IgG1, IgG2b, and IgG2a anti-(T,G)-A--L antibody responses of high-responder F1.nude mice. Press JL; Haber J; Wortis HH J Immunol; 1982 Jan; 128(1):441-6. PubMed ID: 6798113 [TBL] [Abstract][Full Text] [Related]
16. Immunologic responses to a murine mammary adenocarcinoma. I. Passive transfer of immunity by sera from tumor-bearing mice. Yamamura Y; Virella G; Haskill JS Int J Cancer; 1977 May; 19(5):707-16. PubMed ID: 68018 [TBL] [Abstract][Full Text] [Related]
17. In vivo allogeneic effects: shift in the isotype profile of primary TI-2 responses in mice undergoing graft-vs-host reaction. Golding H; Rittenberg MB J Immunol; 1982 Nov; 129(5):1878-82. PubMed ID: 6749981 [TBL] [Abstract][Full Text] [Related]
18. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice. Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462 [TBL] [Abstract][Full Text] [Related]
19. Correlations between humoral immunity and successful chemotherapy-immunotherapy. Cantrell JL; Killion JJ; Kollmorgen GM Cancer Res; 1976 Sep; 36(9 pt.1):3051-7. PubMed ID: 788896 [TBL] [Abstract][Full Text] [Related]
20. Modulation of granulomatous hypersensitivity. IV. Immunoglobulin and antibody production by vigorous and immunomodulated liver granulomas of Schistosoma mansoni-infected mice. Boros DL; Amsden AF; Hood AT J Immunol; 1982 Mar; 128(3):1050-3. PubMed ID: 7035555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]